Resources
AVAC’s Resource Database contains educational and advocacy materials covering a wide range of issues on biomedical prevention of HIV, STIs, COVID-19 and emerging health threats—from research to rollout.
To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database
Results
showing 1-10 of 34
How do People Who Use/Inject Drugs Intersect with PrEP Research and Service Delivery?
On Wednesday, September 6, The Choice Agenda (TCA), the International Network of People Who Use Drugs (INPUD) and our wonderful expert speakers discussed the health and wellness priorities of people who use/inject drugs, and how these communities (“key populations”) intersect across PrEP research, development, and implementation activities.
Prevention Option:
Tales from Two Cities: HIV and STI research highlights from Brisbane and Chicago
TCA’s invited experts will share their highlights and reflections on the HIV and STI-related science presented at two major global health conferences.
ClusterF*#k: Molecular HIV Surveillance, Criminalization, and The Real Risks to PLHIV
Advocates Brian Minalga (Deputy Director of the Office of HIV/AIDS Network Coordination), Amir Sadeghi (Policy and Advocacy Manager at the The Center for HIV Law and Policy), and Andy Spieldenner (Executive Director of MPact Global Action) will explore the intersection of surveillance, bodily autonomy and criminalization.
PrEP That Booty: The latest on rectal microbicide research for the back door
Most of what we hear about regarding the HIV prevention pipeline is about long-acting, longer-acting, and even longer-acting products that deliver drug throughout the body and require a trained clinician to deliver.
Prevention Option:
The Road to and Beyond High-Level Meetings on UHC and PPR
This webinar highlighted key opportunities for community and civil society to engage ahead of and beyond the upcoming high-level meetings on Universal Health Coverage (UHC) and Pandemic Prevention, Preparedness, and Response (PPPR).
Prevention Option:
What’s All the Buzz About: mRNA, manufacturing, vaccine access
AVAC and partners hosted a conversation to explore the potential role of bNAbs in prevention, current status in the field, and key issues to consider in HIV vaccine research. Panelists included: Slim Karim, CAPRISA, Pervin Anklesaria, Bill &...
Prevention Option:
Advancing HIV Cure to Africa: What is needed?
This webinar discussed how researchers, communities and other stakeholders from high income countries could work equitably with low- and middle-income countries in the interests of an HIV cure for all.
Prevention Option:
PrEP (In)equity: Documenting, measuring, and flipping the script towards justice
Tuesday, May 9 at 9:00 AM–10:30AM ET Disparities in PrEP awareness, access, and uptake are stark in the United States, and play out along lines of race, gender, age, and geography. While we see increases in PrEP uptake overall, these metrics tend...
Prevention Option:
HIV Prevention Plus Plus: Developing Options that Meet the Full Range of our Sexual and Reproductive Health Needs
Tuesday, April 25 at 9:00 AM–10:30AM ET Despite a dynamic research and development (R&D) pipeline for prevention products, male and female condoms remain the only multi-purpose prevention technologies (MPTs) currently available. Yet MPTs are...
Prevention Option:
How to Communicate about Sexual Health and STIs: Sex positivity vs. risk-based language
Thursday, April 20 at 9:30 AM – 11:00 AM ET Join The Choice Agenda for a conversation focused on sex positivity and risk-based language when discussing sexual health and STIs. Speakers include Dr. Keosha T. Bond, CUNY School of Medicine, Dr....
showing 1-10 of 34